Filing Details
- Accession Number:
- 0001209191-22-039654
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-28 17:53:00
- Reporting Period:
- 2022-06-24
- Accepted Time:
- 2022-06-28 17:53:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1812364 | Relay Therapeutics Inc. | RLAY | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1709772 | A Donald Bergstrom | C/O Relay Therapeutics, Inc. 399 Binney Street, 2Nd Floor Cambridge MA 02139 | President, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-24 | 8,000 | $4.12 | 100,493 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-06-24 | 8,000 | $20.00 | 92,493 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-06-27 | 999 | $20.31 | 91,494 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-06-24 | 8,000 | $0.00 | 8,000 | $4.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
178,456 | 2028-04-09 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.
- Includes 87,141 shares underlying restricted stock units ("RSUs").
- Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,188 shares of RSUs on June 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- Includes 84,953 shares underlying RSUs.
- Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.